2023-08-10 10:49:49
August 10, 2023 Today at 12:47 PM
Updated at 10 August 2023 12:47
Before the publication of highly anticipated economic indicators in the United States, European markets are in the green this Thursday noon. Wall Street is expected higher.
The main european scholarships are up, this Thursday noon, investors positioning themselves before the release of data on US inflation.
Wall Street is expected in the green at the opening if we trust the futures on the American indices around 12:30 p.m.
In Brussels, the Bel 20
fell by 0.33% at the same time weighed down by KBC. The continuously quoted securities index, for its part, rose by 0.33%.
Read also
The two announcements that bring down KBC
In the wake of his results, KBC fall of 6.2% and is the bottom of the Bel 20. With the exception d’UCB (-0.1%) and Melexis (-0.7%) all index values are in the green.
WDP wins 1.6%, Cofinimmo 1,5%, Ageas 1,5% et Ears 1,3%.
Excluding Bel 20, biotech MDxHealth jumped 10% following a positive announcement in the United States. Nyxoah advance of 4.6% and Immobel of 2.3%.
At the bottom of the table, let’s point KBC Again (-2,1%), Texaf (-4,1%) et EVS (-1,8%).
Briefing actions belges
>Argenx
: Degroof Petercam raised its target price to 558 euros once morest 424 euros before. The recommendation remains to “buy”.
>ING
: UBS raised its price target to 17.6 euros once morest 16.9 euros before. The recommendation remains to “buy”.
: UBS raised its target price to 4.45 euros once morest 4.05 euros before. The recommendation remains at “neutral”.
>Azelis
: ING has reduced its target price to 32.5 euros once morest 34 euros before. The recommendation remains to “buy”.
>Xior
: ING has reduced its target price to 36.5 euros once morest 40 euros before. The recommendation remains to “buy”.
>KBC
posts its best result in 16 years and announces 1.3 billion euros in share buybacks. KBC’s net profit far exceeded expectations in the last quarter. The Belgian heavyweight in the banking sector will reward its shareholders. Our article.
>Ahold Delhaize
:
* Morgan Stanley has reduced its target price to 34 euros once morest 36 euros before. The recommendation remains to “overweight” (buy).
*JP Morgan has reduced its target price to 32.1 euros once morest 33 euros before. The recommendation remains to “overweight” (buy).
>Ontex
will sell its Algerian activities to Hygianis, its local distributor for more than 20 years. The transaction includes Ontex’s activities in Algeria and exports to certain neighboring countries. No details on the amount of the transaction were given. Our article.
>MDxHealth
announces broader partnership with Cigna. MDxHealth reports that Cigna has expanded its commercial and Medicare Advantage coverage to include the company’s Select mdx test for prostate cancer. The press release.
>Biocartis
entered into a new post-commercial collaboration program with Lilly. It will explore the benefits of adding Biocartis’ Idylla platform to a molecular diagnostics workflow in clinical laboratories through a study in hospitals in Spain. The press release.
>Watch out for this Thursday. Belgium. Jensen-Group results following trading. USA. Inflation July 2:30 p.m.
1691668041
#Reviews #brokers #argenx #Ahold #Delhaize #ING #bpost #Xior #KBC #bites #dust #biotech #leaps #Briefing